These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21945758)

  • 21. PI3Kγ ablation does not promote diabetes in
    Breasson L; Sardi C; Becattini B; Zani F; Solinas G
    FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
    Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Diabetic Activities of Gastrodia elata Blume Water Extracts Are Mediated Mainly by Potentiating Glucose-Stimulated Insulin Secretion and Increasing β-Cell Mass in Non-Obese Type 2 Diabetic Animals.
    Yang HJ; Kim MJ; Kwon DY; Kim DS; Lee YH; Kim JE; Park S
    Nutrients; 2016 Mar; 8(3):161. PubMed ID: 26978400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.
    Shao JQ; Iwashita N; Du H; Wang YT; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Acta Pharmacol Sin; 2007 Feb; 28(2):246-57. PubMed ID: 17241528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice.
    Okauchi S; Shimoda M; Obata A; Kimura T; Hirukawa H; Kohara K; Mune T; Kaku K; Kaneto H
    Biochem Biophys Res Commun; 2016 Feb; 470(3):772-782. PubMed ID: 26505796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.
    Oshima H; Yoshida S; Ohishi T; Matsui T; Tanaka H; Yonetoku Y; Shibasaki M; Uchiyama Y
    Life Sci; 2013 Feb; 92(2):167-73. PubMed ID: 23246743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of p38 mitogen-activated protein kinase exerts a hypoglycemic effect by improving β cell function via inhibition of β cell apoptosis in db/db mice.
    Wei X; Gu N; Feng N; Guo X; Ma X
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1494-1500. PubMed ID: 30284474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.
    Chu KY; Lau T; Carlsson PO; Leung PS
    Diabetes; 2006 Feb; 55(2):367-74. PubMed ID: 16443769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis.
    Huang JS; Guo BB; Wang GH; Zeng LM; Hu YH; Wang T; Wang HY
    Acta Pharmacol Sin; 2021 Feb; 42(2):264-271. PubMed ID: 32737468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice].
    Shao JQ; Iwashita N; Du H; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):306-10. PubMed ID: 17637271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy.
    Gao Q; Qin WS; Jia ZH; Zheng JM; Zeng CH; Li LS; Liu ZH
    Planta Med; 2010 Jan; 76(1):27-33. PubMed ID: 19639539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
    Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
    Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
    Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservative effect of electrolyzed reduced water on pancreatic beta-cell mass in diabetic db/db mice.
    Kim MJ; Jung KH; Uhm YK; Leem KH; Kim HK
    Biol Pharm Bull; 2007 Feb; 30(2):234-6. PubMed ID: 17268057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
    Diani AR; Sawada G; Wyse B; Murray FT; Khan M
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β-cells in db/db mice: The earlier and longer, the better.
    Kimura T; Obata A; Shimoda M; Okauchi S; Kanda-Kimura Y; Nogami Y; Moriuchi S; Hirukawa H; Kohara K; Nakanishi S; Mune T; Kaku K; Kaneto H
    Diabetes Obes Metab; 2018 Oct; 20(10):2442-2457. PubMed ID: 29873444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.